glp-1 stopping Researchers find medications safe to continue before surgery in patients with diabetes and obesity New analysis of GLP-1 drugs

Some patients may successfully transition to lower maintenance doses, while others may benefit from combining pharmacotherapy with intensive lifestyle interventions

Adults with Overweight & Comorbidities: Individuals with a BMI of 27 kg/m or higher who also have at least one weight-related medical condition, such as hypertension (high blood pressure), type 2 diabetes, or dyslipidemia (high cholesterol)

Mounjaro, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight and maintain their weight loss, according to a study published Monday in JAMA Internal Medicine

"It's an adjustment for patients, because in our culture we do so much socialization around food," Rothberg says

C., & Stefanski, A